Literature DB >> 23250308

[Severe pneumococcal infections in the elderly - preventable by vaccination].

H Hof1, A Fahr, M Holfelder, R Schwarz, K Oberdorfer.   

Abstract

Elderly people are more susceptible to pneumococcal infections. Data in Germany from 2005-2010 shows that especially seniors are prone to develop serious complications such as sepsis. Women are obviously less affected than men. Most of the infections occurred during the winter months. The majority of isolates, i.e., about 80%, possess capsular polysaccharide antigens which are represented in the 23-valent vaccine. Consequently, it could be assumed that the severe complications ensuing long hospital stays and associated with a high mortality could have been avoided, if the elderly people would have been vaccinated, which, however, was only true in a small proportion (28%). Recently, a new conjugated vaccine was introduced to the market. In principle, several antibiotics are available for direct antibacterial treatment. All isolates are susceptible to cefotaxime as well as to ceftriaxone. Resistance to penicillin as well as ampicillin is very rare in Germany. The vast majority of isolates are susceptible to quinolones such as levofloxacin and moxifloxacin. Resistance to macrolides, for example to erythromycin, occurs to a certain extent but the percentage has been declining in recent years. Nevertheless, in many instances therapy is too late. Thus, prevention is of great importance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23250308     DOI: 10.1007/s00391-012-0339-x

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  20 in total

1.  [Pneumococcal pneumonia despite vaccination? What is the value of these vaccines for seniors?].

Authors:  Horst Gross
Journal:  MMW Fortschr Med       Date:  2010-09-30

2.  Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.

Authors:  Angel Vila-Córcoles; Olga Ochoa-Gondar; Imma Hospital; Xabier Ansa; Angels Vilanova; Teresa Rodríguez; Carl Llor
Journal:  Clin Infect Dis       Date:  2006-08-21       Impact factor: 9.079

3.  Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.

Authors:  Birgit Simell; Arja Vuorela; Nina Ekström; Arto Palmu; Antti Reunanen; Seppo Meri; Helena Käyhty; Merja Väkeväinen
Journal:  Vaccine       Date:  2011-01-12       Impact factor: 3.641

Review 4.  Ageing and infection.

Authors:  Gaëtan Gavazzi; Karl-Heinz Krause
Journal:  Lancet Infect Dis       Date:  2002-11       Impact factor: 25.071

5.  The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.

Authors:  Merit Melin; Krzysztof Trzciński; Seppo Meri; Helena Käyhty; Merja Väkeväinen
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

Review 6.  Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

Authors:  Katherine L O'Brien; Michael Hochman; David Goldblatt
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.

Authors:  Victor L Yu; Christine C C Chiou; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Larry M Baddour; Carlos M Luna; David R Snydman; Margaret Ip; Wen Chien Ko; M Bernadete F Chedid; Antoine Andremont; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2003-07-07       Impact factor: 9.079

8.  Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003.

Authors:  Carla A Winston; Pascale M Wortley; Karen A Lees
Journal:  J Am Geriatr Soc       Date:  2006-02       Impact factor: 5.562

9.  Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.

Authors:  M Imöhl; R R Reinert; M van der Linden
Journal:  Clin Microbiol Infect       Date:  2009-07-20       Impact factor: 8.067

Review 10.  Vaccines for older adults.

Authors:  Sum Lam; Tomas Z Jodlowski
Journal:  Consult Pharm       Date:  2009-05
View more
  1 in total

1.  A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: patient knowledge, awareness, and attitudes of vaccination and prevalence rates by socioeconomic status.

Authors:  Shoukat Ali Baig; Maroof Hassan; Syed Mustajab Ahmed; Wardah Moazzam; Ailya Inayat
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.